Central Line-Associated Bloodstream Infections

CLABSI: Definition & Epidemiology - Line Lurkers

• Definition (CDC/NHSN): Lab-confirmed bloodstream infection (LCBI) with a central line (CL) in situ.

  ⭐ CLABSI: LCBI with CL/umbilical catheter in place >2 calendar days (Day 1=placement day) on event date; line present on event date or day before.

• Key Points:
  • If CL removed, infection within 2 days post-removal can be CLABSI.
• Epidemiology:
  • Rate: Infections / 1000 CL-days.
  • ICU rates (India: ~2-5/1000 CL-days) > non-ICU.
• Impact:
  • ↑ Morbidity, hospital stay.
  • ↑ Mortality (attributable: 12-25%).
  • ↑ Healthcare costs.

CLABSI: Microbiology & Pathogenesis - Culprit Crew

• Pathogenesis: Key routes for microbial entry & persistence.

  • Extraluminal: Skin flora at insertion site or hub contamination; microbes migrate along external catheter surface.
  • Intraluminal: Contaminated infusates or catheter hubs; microbes migrate through catheter lumen.
  • Hematogenous: Seeding from another infection site (less common).
  • Biofilm Formation: Microbes adhere to catheter, encase in a self-produced matrix, shielding from antibiotics & host defenses.

• Common Pathogens: 📌 SKECKY-P (Staph, Klebsiella, E.coli, Candida, Enterococcus, Pseudomonas)

  Organism	Gram Stain	Key Features/Virulence	Common Resistance (India)
  Coagulase-neg Staph (CoNS)	GPC	Biofilm, skin flora	Methicillin (MRCoNS)
  Staphylococcus aureus	GPC	Biofilm, toxins	MRSA
  Enterococcus spp.	GPC	Biofilm	VRE
  Candida spp.	Fungus	Biofilm, C. auris (MDR)	Fluconazole-R
  Klebsiella pneumoniae	GNB	Biofilm, ESBL, Carbapenemases (NDM)	CRE
  Pseudomonas aeruginosa	GNB	Biofilm, efflux pumps	MDR
  Escherichia coli	GNB	Biofilm, ESBL	ESBL, CRE

⭐ Coagulase-negative staphylococci are the most common cause of CLABSI, often originating from the patient's skin flora and forming biofilms on the catheter surface.

CLABSI: Prevention Strategies - Shield Up!

• Strict hand hygiene & full aseptic techniques.
• Implement evidence-based insertion & maintenance bundles.
• Staff education, training & verified competency.
• CLABSI surveillance & regular performance feedback.

📌 Insertion Bundle: I-HI-CLIP (Identify need, Hand hygiene, $CHG$ skin prep (>0.5%), Optimal Site, Insertion with Maximal Barrier, Protective Dressing)

⭐ Strict adherence to prevention bundles can ↓ CLABSI rates by >50%.

CLABSI: Diagnosis & Treatment - Zap the Zap

• Clinical Signs:
  • Local: Catheter site inflammation (erythema, pain, discharge/purulence).
  • Systemic: New-onset fever, chills, hypotension, or other signs of sepsis in a patient with CVC.
• Diagnosis:
  • Crucial: Paired blood cultures (central line & peripheral vein).
  • Strong indicators:
    • Differential Time to Positivity (DTP) >2 hours (central culture positive earlier).
    • Quantitative cultures: Central line colony count 3-5x > peripheral.
  • Confirmatory: Same organism from catheter tip (>15 CFU semiquantitative) and peripheral blood.
  • Supportive: ↑ CRP, ↑ Procalcitonin.
• Treatment Goals: Rapid pathogen eradication, CVC management (removal vs. salvage), prevent complications.

⭐ For CLABSI due to S. aureus, Pseudomonas aeruginosa, or Candida spp., prompt catheter removal is generally recommended along with systemic antimicrobial therapy.

High‑Yield Points - ⚡ Biggest Takeaways

• CLABSI: Infection >48 hours post-central line, no other source.
• Common pathogens: CoNS (Coagulase-negative Staphylococci), S. aureus, Enterococcus, Candida.
• Prevention: Aseptic techniques, chlorhexidine skin prep, maximal barrier precautions.
• CLABSI care bundles are crucial for reducing infection rates.
• Diagnosis: Paired blood cultures (central & peripheral) with differential time to positivity (DTP) >2 hours.
• Catheter tip: >15 CFU (Maki roll) or >10^3 CFU/mL (quantitative) suggests infection.
• Management: Empiric antibiotics; catheter removal is often essential for resolution.